Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Influenza

  Free Subscription


25.01.2021

7 Ann Intern Med
1 Arch Virol
4 BMJ
2 Epidemiol Infect
1 J Immunol
4 J Infect Dis
2 J Virol
5 J Virol Methods
4 JAMA
4 Lancet
4 MMWR Morb Mortal Wkly Rep
5 N Engl J Med
2 PLoS Comput Biol
1 PLoS Med
30 PLoS One
7 Proc Natl Acad Sci U S A
6 Vaccine
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. HAMAD Y, Joynt-Maddox KE, Powderly WG
    COVID-19 and Outpatient Parenteral Antimicrobial Therapy.
    Ann Intern Med. 2021;174:142.
    PubMed        

  2. CLANCY CM, Kirsh S
    Virtual Care and the Pandemic: Are We Reaching All Patients?
    Ann Intern Med. 2021;174:116-117.
    PubMed        

  3. KOPLAN J, Ostroff SM, Mokdad AH
    Maxims for a Pandemic: Time, Distance, and Data.
    Ann Intern Med. 2021;174:111-112.
    PubMed        

  4. MACKEY K, Kansagara D, Vela K
    Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Ann Intern Med. 2020 Dec 1. doi: 10.7326/L20-1355.
    PubMed        

  5. LAX SF, Skok K, Zechner PM, Trauner M, et al
    Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome.
    Ann Intern Med. 2021;174:139-140.
    PubMed        

  6. NICHOLS L
    Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome.
    Ann Intern Med. 2021;174:139.
    PubMed        

  7. MATHUR P
    COVID-19 and Outpatient Parenteral Antimicrobial Therapy.
    Ann Intern Med. 2021;174:141-142.
    PubMed        


    Arch Virol

  8. NG KT, Takebe Y, Kamarulzaman A, Tee KK, et al
    Genome sequencing and phylogenetic reconstruction reveal a potential fourth rhinovirus species and its worldwide distribution.
    Arch Virol. 2021;166:225-229.
    PubMed         Abstract available


    BMJ

  9. SOKOL D
    The NHS is not at risk of being overwhelmed-it already is.
    BMJ. 2021;372:n62.
    PubMed        

  10. RAZAI MS, Kankam HKN, Majeed A, Esmail A, et al
    Mitigating ethnic disparities in covid-19 and beyond.
    BMJ. 2021;372:m4921.
    PubMed        

  11. GLOVER RE, Urquhart R, Lukawska J, Blumenthal KG, et al
    Vaccinating against covid-19 in people who report allergies.
    BMJ. 2021;372:n120.
    PubMed        

  12. MANTHORPE J, Iliffe S
    Care homes: averting market failure in a post-covid-19 world.
    BMJ. 2021;372:n118.
    PubMed        


    Epidemiol Infect

  13. FERNANDEZ-SALINAS J, Aragon-Caqueo D, Valdes G, Laroze D, et al
    Modelling pool testing for SARS-CoV-2: addressing heterogeneity in populations.
    Epidemiol Infect. 2020;149:e9.
    PubMed         Abstract available

  14. LIANG C, Shen L
    An analysis of coronavirus disease 2019 with spline regression at province level during first-level response to major public health emergency out of Hubei, China.
    Epidemiol Infect. 2021;149:e10.
    PubMed         Abstract available


    J Immunol

  15. HANSEN CB, Jarlhelt I, Perez-Alos L, Hummelshoj Landsy L, et al
    SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
    J Immunol. 2021;206:109-117.
    PubMed         Abstract available


    J Infect Dis

  16. CHIRIKOV VV, Simoes EAF, Kuznik A, Kwon Y, et al
    Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;221:1244-1255.
    PubMed         Abstract available

  17. PIEDRA PA
    Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect.
    J Infect Dis. 2020;221:1205-1207.
    PubMed        

  18. SIMOES EAF, Chirikov V, Botteman M, Kwon Y, et al
    Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    J Infect Dis. 2020;221:1256-1270.
    PubMed         Abstract available

  19. SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
    The feasibility and performance of participant-collected mid-turbinate nasal swabs for detection of influenza virus, respiratory syncytial virus, and human metapneumovirus infections among pregnant women.
    J Infect Dis. 2021 Jan 18. pii: 6103926. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  20. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    PubMed         Abstract available

  21. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    PubMed         Abstract available


    J Virol Methods

  22. SILVA JUNIOR JVJ, Merchioratto I, de Oliveira PSB, Rocha Lopes TR, et al
    End-point RT-PCR: A potential alternative for diagnosing coronavirus disease 2019 (COVID-19).
    J Virol Methods. 2021;288:114007.
    PubMed         Abstract available

  23. MARIEN J, Ceulemans A, Michiels J, Heyndrickx L, et al
    Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
    J Virol Methods. 2021;288:114025.
    PubMed         Abstract available

  24. KRUTTGEN A, Cornelissen CG, Dreher M, Hornef MW, et al
    Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit.
    J Virol Methods. 2021;288:114024.
    PubMed         Abstract available

  25. VON RHEIN C, Scholz T, Henss L, Kronstein-Wiedemann R, et al
    Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma.
    J Virol Methods. 2021;288:114031.
    PubMed         Abstract available

  26. XIAO Y, Li Z, Wang X, Wang Y, et al
    Comparison of three TaqMan real-time reverse transcription-PCR assays in detecting SARS-CoV-2.
    J Virol Methods. 2021;288:114030.
    PubMed         Abstract available


    JAMA

  27. WOOLF SH, Chapman DA, Lee JH
    COVID-19 as the Leading Cause of Death in the United States.
    JAMA. 2020 Dec 17. pii: 2774465. doi: 10.1001/jama.2020.24865.
    PubMed        

  28. ABBASI J
    JAMA Network Articles of the Year 2020.
    JAMA. 2020;324:2350-2353.
    PubMed        

  29. VOLPP KG, Loewenstein G, Buttenheim AM
    Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
    JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
    PubMed        

  30. ERFANI P, Uppal N, Lee CH, Mishori R, et al
    COVID-19 Testing and Cases in Immigration Detention Centers, April-August 2020.
    JAMA. 2020 Oct 29. pii: 2772627. doi: 10.1001/jama.2020.21473.
    PubMed        


    Lancet

  31. SHAW A, Flott K, Fontana G, Durkin M, et al
    No patient safety without health worker safety.
    Lancet. 2020;396:1541-1543.
    PubMed        

  32. CORTINOVIS M, Perico N, Remuzzi G
    Long-term follow-up of recovered patients with COVID-19.
    Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
    PubMed        

  33. DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
    Using EM data to understand COVID-19 pathophysiology.
    Lancet. 2021;397:196-197.
    PubMed        

  34. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Lancet. 2021;397:197-198.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  35. SPENCER KD, Chung CL, Stargel A, Shultz A, et al
    COVID-19 Case Investigation and Contact Tracing Efforts from Health Departments - United States, June 25-July 24, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:83-87.
    PubMed         Abstract available

  36. PRINCE-GUERRA JL, Almendares O, Nolen LD, Gunn JKL, et al
    Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:100-105.
    PubMed         Abstract available

  37. GALLOWAY SE, Paul P, MacCannell DR, Johansson MA, et al
    Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:95-99.
    PubMed         Abstract available

  38. LEIDMAN E, Duca LM, Omura JD, Proia K, et al
    COVID-19 Trends Among Persons Aged 0-24 Years - United States, March 1-December 12, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:88-94.
    PubMed         Abstract available


    N Engl J Med

  39. LEITER RE
    Reentry.
    N Engl J Med. 2020;383:e141.
    PubMed        

  40. RUBIN D, Chan-Tack K, Farley J, Sherwat A, et al
    FDA Approval of Remdesivir - A Step in the Right Direction.
    N Engl J Med. 2020;383:2598-2600.
    PubMed        

  41. CHATTERJEE P, Sommers BD, Joynt Maddox KE
    Essential but Undefined - Reimagining How Policymakers Identify Safety-Net Hospitals.
    N Engl J Med. 2020;383:2593-2595.
    PubMed        

  42. PERRIN JM, Kenney GM, Rosenbaum S
    Medicaid and Child Health Equity.
    N Engl J Med. 2020;383:2595-2598.
    PubMed        

  43. COHEN MS
    Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection.
    N Engl J Med. 2021;384:289-291.
    PubMed        


    PLoS Comput Biol

  44. LIU QH, Bento AI, Yang K, Zhang H, et al
    The COVID-19 outbreak in Sichuan, China: Epidemiology and impact of interventions.
    PLoS Comput Biol. 2020;16:e1008467.
    PubMed         Abstract available

  45. KREEGER PK, Brock A, Gibbs HC, Grande-Allen KJ, et al
    Ten simple rules for women principal investigators during a pandemic.
    PLoS Comput Biol. 2020;16:e1008370.
    PubMed        


    PLoS Med

  46. SELIGMAN B, Ferranna M, Bloom DE
    Social determinants of mortality from COVID-19: A simulation study using NHANES.
    PLoS Med. 2021;18:e1003490.
    PubMed         Abstract available


    PLoS One

  47. KIBRET S, Teshome D, Fenta E, Hunie M, et al
    Prevalence of anxiety towards COVID-19 and its associated factors among healthcare workers in a Hospital of Ethiopia.
    PLoS One. 2020;15:e0243022.
    PubMed         Abstract available

  48. CHANDRATRE S, Soman A
    Preparing for the interviewing process during Coronavirus disease-19 pandemic: Virtual interviewing experiences of applicants and interviewers, a systematic review.
    PLoS One. 2020;15:e0243415.
    PubMed         Abstract available

  49. FENG S, Feng Z, Ling C, Chang C, et al
    Prediction of the COVID-19 epidemic trends based on SEIR and AI models.
    PLoS One. 2021;16:e0245101.
    PubMed         Abstract available

  50. ABD ELAZIZ M, A A Al-Qaness M, Abo Zaid EO, Lu S, et al
    Automatic clustering method to segment COVID-19 CT images.
    PLoS One. 2021;16:e0244416.
    PubMed         Abstract available

  51. VARONA L, Gonzales JR
    Dynamics of the impact of COVID-19 on the economic activity of Peru.
    PLoS One. 2021;16:e0244920.
    PubMed         Abstract available

  52. BRIDGLAND VME, Moeck EK, Green DM, Swain TL, et al
    Why the COVID-19 pandemic is a traumatic stressor.
    PLoS One. 2021;16:e0240146.
    PubMed         Abstract available

  53. SHAIBU JO, Onwuamah CK, James AB, Okwuraiwe AP, et al
    Full length genomic sanger sequencing and phylogenetic analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Nigeria.
    PLoS One. 2021;16:e0243271.
    PubMed         Abstract available

  54. GARNERET P, Coz E, Martin E, Manuguerra JC, et al
    Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.
    PLoS One. 2021;16:e0243712.
    PubMed         Abstract available

  55. KENNEDY AP, Yam SCP
    On the authenticity of COVID-19 case figures.
    PLoS One. 2020;15:e0243123.
    PubMed         Abstract available

  56. ABDULLAHI L, Onyango JJ, Mukiira C, Wamicwe J, et al
    Community interventions in Low-And Middle-Income Countries to inform COVID-19 control implementation decisions in Kenya: A rapid systematic review.
    PLoS One. 2020;15:e0242403.
    PubMed         Abstract available

  57. RAZZAK JA, Bhatti JA, Tahir MR, Pasha-Razzak O, et al
    Initial estimates of COVID-19 infections in hospital workers in the United States during the first wave of pandemic.
    PLoS One. 2020;15:e0242589.
    PubMed         Abstract available

  58. HAN Y, Luo Z, Zhai W, Zheng Y, et al
    Comparison of the clinical manifestations between different age groups of patients with overseas imported COVID-19.
    PLoS One. 2020;15:e0243347.
    PubMed         Abstract available

  59. MURRAY AT
    Planning for classroom physical distancing to minimize the threat of COVID-19 disease spread.
    PLoS One. 2020;15:e0243345.
    PubMed         Abstract available

  60. YANG X, Xiong Z, Li Z, Li X, et al
    Perceived psychological stress and associated factors in the early stages of the coronavirus disease 2019 (COVID-19) epidemic: Evidence from the general Chinese population.
    PLoS One. 2020;15:e0243605.
    PubMed         Abstract available

  61. CARTAUD A, Quesque F, Coello Y
    Wearing a face mask against Covid-19 results in a reduction of social distancing.
    PLoS One. 2020;15:e0243023.
    PubMed         Abstract available

  62. DORJEE K, Kim H, Bonomo E, Dolma R, et al
    Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    PLoS One. 2020;15:e0243191.
    PubMed         Abstract available

  63. LLABRES M, Valiente G
    Alignment of virus-host protein-protein interaction networks by integer linear programming: SARS-CoV-2.
    PLoS One. 2020;15:e0236304.
    PubMed         Abstract available

  64. CALVEZ R, Taylor A, Calvo-Bado L, Fraser D, et al
    Molecular detection of SARS-CoV-2 using a reagent-free approach.
    PLoS One. 2020;15:e0243266.
    PubMed         Abstract available

  65. BHATIA R, Klausner J
    Estimating individual risks of COVID-19-associated hospitalization and death using publicly available data.
    PLoS One. 2020;15:e0243026.
    PubMed         Abstract available

  66. MARGRAF J, Brailovskaia J, Schneider S
    Behavioral measures to fight COVID-19: An 8-country study of perceived usefulness, adherence and their predictors.
    PLoS One. 2020;15:e0243523.
    PubMed         Abstract available

  67. IDE K, Asami T, Suda A, Yoshimi A, et al
    The psychological effects of COVID-19 on hospital workers at the beginning of the outbreak with a large disease cluster on the Diamond Princess cruise ship.
    PLoS One. 2021;16:e0245294.
    PubMed         Abstract available

  68. LEV S, Gottesman T, Sahaf Levin G, Lederfein D, et al
    Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19.
    PLoS One. 2021;16:e0245296.
    PubMed         Abstract available

  69. ARROYO-MARIOLI F, Bullano F, Kucinskas S, Rondon-Moreno C, et al
    Tracking [Formula: see text] of COVID-19: A new real-time estimation using the Kalman filter.
    PLoS One. 2021;16:e0244474.
    PubMed         Abstract available

  70. REISS S, Franchina V, Jutzi C, Willardt R, et al
    From anxiety to action-Experience of threat, emotional states, reactance, and action preferences in the early days of COVID-19 self-isolation in Germany and Austria.
    PLoS One. 2020;15:e0243193.
    PubMed         Abstract available

  71. NAGY A, Cernikova L, Kunteova K, Dirbakova Z, et al
    A universal RT-qPCR assay for "One Health" detection of influenza A viruses.
    PLoS One. 2021;16:e0244669.
    PubMed         Abstract available

  72. GOIC M, Bozanic-Leal MS, Badal M, Basso LJ, et al
    COVID-19: Short-term forecast of ICU beds in times of crisis.
    PLoS One. 2021;16:e0245272.
    PubMed         Abstract available

  73. ZUCCHI D, Tani C, Elefante E, Stagnaro C, et al
    Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
    PLoS One. 2021;16:e0245274.
    PubMed         Abstract available

  74. VAHIDY FS, Pan AP, Ahnstedt H, Munshi Y, et al
    Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area.
    PLoS One. 2021;16:e0245556.
    PubMed         Abstract available

  75. KROO L, Kothari A, Hannebelle M, Herring G, et al
    Modified full-face snorkel masks as reusable personal protective equipment for hospital personnel.
    PLoS One. 2021;16:e0244422.
    PubMed         Abstract available

  76. HASAN ATMH, Das SC, Islam MS, Mansur M, et al
    Impact of COVID-19 on hospital admission of acute stroke patients in Bangladesh.
    PLoS One. 2021;16:e0240385.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  77. ANDRASFAY T, Goldman N
    Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  78. YIANNOUTSOS CT, Halverson PK, Menachemi N
    Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  79. MITZE T, Kosfeld R, Rode J, Walde K, et al
    Face masks considerably reduce COVID-19 cases in Germany.
    Proc Natl Acad Sci U S A. 2020;117:32293-32301.
    PubMed         Abstract available

  80. WEITZ JS, Park SW, Eksin C, Dushoff J, et al
    Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.
    Proc Natl Acad Sci U S A. 2020;117:32764-32771.
    PubMed         Abstract available

  81. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed         Abstract available

  82. SASISEKHARAN V, Pentakota N, Jayaraman A, Tharakaraman K, et al
    Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  83. SCHMELZ K
    Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  84. REEMERS S, Verstegen I, Basten S, Hubers W, et al
    A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00022.
    PubMed         Abstract available

  85. CAO L, Lou J, Zhao S, Chan RWY, et al
    In silico prediction of influenza vaccine effectiveness by sequence analysis.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00006.
    PubMed         Abstract available

  86. WHITAKER JA, Parikh SA, Shanafelt TD, Kay NE, et al
    The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
    Vaccine. 2021 Jan 15. pii: S0264-410X(21)00001.
    PubMed         Abstract available

  87. GUALANO MR, Corradi A, Voglino G, Catozzi D, et al
    Healthcare Workers' (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31655.
    PubMed         Abstract available

  88. AKMATOV MK, Holstiege J, Steffen A, Batzing J, et al
    Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31693.
    PubMed         Abstract available

  89. WIEMKEN TL, Rutschman AS
    Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00018.
    PubMed        


    Virus Res

  90. AKIYAMA Y, Sakashita K, Arihara M, Kimura Y, et al
    COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air.
    Virus Res. 2021;293:198259.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: